ARS Pharmaceuticals, Inc. (SPRY)
10.45
+0.52
(+5.24%)
USD |
NASDAQ |
Dec 10, 16:00
10.45
0.00 (0.00%)
After-Hours: 16:38
ARS Pharmaceuticals Shareholders Equity (Quarterly): 147.66M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Lipocine, Inc. | 14.14M |
| KalVista Pharmaceuticals, Inc. | 17.00M |
| Vivos Therapeutics, Inc. | 2.532M |
| MBX Biosciences, Inc. | 387.54M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.80M |
| Total Liabilities (Quarterly) | 225.15M |
| Debt to Equity Ratio | 0.6621 |
| Current Ratio | 6.660 |
| Net Debt Paydown Yield | -1.96% |